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Aim To assess the reasons for low influenza vaccination 
coverage in Poland, including knowledge of influenza and 
attitudes toward influenza vaccination.
Methods  This  was  a  cross-sectional,  anonymous,  self-
administered survey in primary care patients in Lodzkie 
voivodship (central Poland). The study participants were 
adults who visited their primary care physicians for various 
reasons from January 1 to April 30, 2007.
Results  Six  hundred  and  forty  participants  completed 
the survey. In 12 months before the study, 20.8% partici-
pants had received influenza vaccination. The most com-
mon reasons listed by those who had not been vaccinat-
ed were good health (27.6%), lack of trust in vaccination 
effectiveness (16.8%), and the cost of vaccination (9.7%). 
The most common source of information about influenza 
vaccination were primary care physicians (46.6%). Despite 
reasonably good knowledge of influenza, as many as ap-
proximately 20% of participants could not point out any 
differences between influenza and other viral respiratory 
tract infections.
Conclusions The main reasons for low influenza vacci-
nation coverage in Poland were patients’ misconceptions 
and the cost of vaccination. Therefore, free-of-charge vac-
cination and more effective informational campaigns are 
needed, with special focus on high-risk groups.
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Due to natural variation, influenza incidence in Poland has 
dropped  significantly  over  the  last  years  in  comparison 
with some years of the last decade of the 20th century. It 
is nevertheless still high: data from 2008 point to the in-
cidence of approximately 600 per 100 000 population (1). 
The real incidence of the disease is underestimated, as the 
considerable portion of influenza cases and the resulting 
hospitalizations are still not registered (2). Moreover, char-
acteristic for influenza is the occurrence of periodic pan-
demics. Thus, medical consequences of influenza in the 
country are serious, putting this infection in the focus of 
the public health measures.
An effective method of reducing influenza morbidity and 
mortality is vaccination. There are several inactivated influ-
enza vaccines available in Poland, which were proven to 
prevent influenza infection and its complications in up to 
70%-90% of vaccinated persons (2,3).
Since 1994, influenza vaccination has been recommended 
by national Protective Vaccination Program. Currently, it is 
recommended for healthy children (from 6 months to 18 
years), elderly patients (55 and over), patients with chronic 
conditions (asthma, diabetes, heart failure, pulmonary dys-
function, and renal failure), and those with low immunity 
(4). However, vaccination is still not reimbursed from the 
national health insurance and the patients need to pay 
100% of the price themselves. The average cost of the vac-
cine approximates € 8. Several initiatives undertaken by lo-
cal authorities in the recent years enabled some high-risk 
patient groups provision of free of charge influenza vac-
cination (5). Unfortunately, these initiatives have been lim-
ited and have not resulted in significant improvements in 
influenza vaccination coverage.
Influenza virus tends to create new strains, characterized 
by diverse antigen structures. For this reason, the vaccine 
is modified yearly, according to the recommendations of 
the World Health Organization (6). Consequently, effective 
influenza protection is only achievable provided that the 
vaccination is repeated every year. This makes the influ-
enza vaccination acceptance even more challenging. Re-
cent reports suggest that the influenza vaccination cover-
age in Poland is far from satisfactory, actually one of the 
lowest in Europe (7,8). According to recent Vaccine Euro-
pean New Integrated Collaboration Effort Project publica-
tion, the number of influenza vaccine doses used in Poland 
during 2007-8 influenza season in high-risk groups (those 
aged over 65 and with underlying conditions) was lowest 
among the 15 studied European countries (9).
In order to help design future informational campaigns, 
the aim of this study was to assess the knowledge of influ-
enza and attitudes toward influenza vaccination as factors 
related to low influenza vaccination coverage in Poland.
MAteriAl AnD MethoDS
This  was  a  cross-sectional,  anonymous,  self-administered 
survey on a convenience sample (n = 640) of primary care 
patients aged 18 and over in Lodzkie voivodship (central Po-
land) in the period January 1 to April 30, 2007 (Table 1). The 
patients visited their primary care physicians for various rea-
sons and as healthy companions of sick patients. The survey 
was based on a 28-item questionnaire, specially constructed 
for this purpose, including questions (in most cases open-
ended) assessing patients’ knowledge of influenza (12 items, 
including 8 open-ended questions), attitudes toward influ-
enza vaccination (5 items, including 2 open-ended ques-
tions), practice of influenza vaccination (4 items), and pa-
tAble 1. Comparison of sociodemographic characteristics 
between the study participants and general population of 
Poland
Characteristic
no. (%) of 
participants (n = 640)
General 
population (%)*
Age:
range   20-90
average 
(±standard deviation)
  46.3 ± 16.6
18-54 years 426 (66.6) 67.4
55 years and more 214 (33.4) 33.6
Sex:
women 359 (56.1) 52.4
men 281 (43.9) 42.7
occupation:
blue-collar workers   60 (9.4)
44.7
white-collar workers 195 (30.5)
students   71 (11.1)   6.1
farmers     5 (0.8)   6.8
unemployed   29 (4.5)   6.1
pensioners 123 (19.2) 30.2
other   45 (7.0)
not provided 112 (17.5)
Place of residence 
(population):
<10 000   98 (15.3) 45.0
10 000-50 000 147 (23.0) 17.9
50 000-100 000   50 (7.8)   8.4
100 000-500 000   86 (13.4) 17.2
>500 000 258 (40.3) 11.5
*Data for general population of Poland (age 18 and older), according 
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tients’ characteristics (7 items). The English translation of the 
questionnaire is available in the web-extra material 1.
The data were analyzed by descriptive statistics. Participants 
were divided into two groups: 18-54 years and 55 years and 
older, according to the definition of high-risk groups in the 
national recommendations on influenza vaccination (4). For 
the analysis of qualitative variables, χ2 test was used.
reSultS
Knowledge of influenza and influenza vaccination
The majority of participants (93.0%) believed that influenza 
was transmitted through the air and 25.9% believed that 
the infection could be caught by sharing kitchen uten-
sils with the sick person (Table 2). Other ways of influen-
za spread were mentioned by fewer than 10% of partici-
pants.
As symptoms characteristic for the initial stage of the in-
fection, participants most often mentioned high tempera-
ture (82.0%), runny nose (39.8%), and muscle pain (39.1%). 
As characteristics differentiating influenza from the com-
mon cold, participants most often mentioned higher and 
longer-lasting temperature (27.2%), complications (23.1%), 
heavier course of the sickness (22.5%), as well as muscle, 
bone, and joint pains (15.0%). However, 17.8% of partici-
pants could not list any symptom differentiating the com-
mon cold from influenza and 3.1% of them believed that 
these conditions did not differ at all. The vast majority of 
participants (91.1%) were convinced that influenza infec-
tion could be dangerous for health; as its dangerous con-
sequences, participants most often mentioned heart dis-
eases (47.0%) and respiratory tract infections (27.8%).
When asked which groups of people “should by all means 
receive  influenza  vaccine,”  participants  in  the  first  place 
mentioned elderly people (41.9%), children (36.9%), and 
people with low immunity to viral infections (25.0%). When 
asked who did not need to be vaccinated, participants 
mentioned healthy and immune people (12.7%), as well 
as the ill, including those with chronic diseases (11.1%). 
A considerable part of the participants did not know any 
contraindications  for  the  vaccination  (42.5%)  and  4.7% 
mentioned pregnant and breastfeeding women as groups 
who should avoid vaccination.
According to 66.3% of the participants, it was best to 
receive vaccination in autumn. The majority of the 
item Percentage (%)
Most frequent ways of influenza virus 
transmission:*
droplet infection 93.0
common cutlery and dishes 25.9
contaminated food products   8.6
contact with infected blood   6.1
breast-feeding   5.3
sexual contact   3.3
difficult to say   5.5
initial symptoms of influenza:†
fever 82.0
runny nose 39.8
muscle pain 39.1
headache 29.2
malaise 28.6
cough 26.3
bones and joints aches 21.1
chills 14.8
sore throat   7.7
gastrointestinal symptoms   2.3
in what sense is influenza different from the 
common cold?†
higher, longer-lasting temperature 27.2
influenza leads to complications 23.1
Influenza has more severe symptoms 22.5
I do not know 17.8
muscle, bone, and joints aches 15.0
influenza is a viral disease 10.3
long-lasting malaise and weakness   5.8
cough and runny nose   4.5
there is no difference   3.1
headache   1.9
influenza should be treated with antibiotics   1.4
gastrointestinal symptoms   1.3
influenza is accompanied by airways 
inflammation
  1.3
influenza should not be treated with antibiotics   1.3
influenza occurs in epidemics   0.5
is influenza hazardous to one’s health?
yes 91.1
no   2.2
difficult to say   6.6
Which influenza consequences might be 
hazardous for one’s life?†
heart diseases 47.1
respiratory disease 27.8
inflammatory complications 15.3
I do not know 14.8
arthritis 10.3
tAble 2. Knowledge of influenza and influenza vaccination 
among study participants from Poland (n = 640)129 Kardas et al: Reasons for low influenza vaccination coverage
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participants (63.4%) were aware that influenza vaccination 
should be repeated every year. However, every fourth par-
ticipant (25.6%) did not have an opinion on that subject. 
Almost 20% of the participants believed that influenza vac-
cination improved immunity to all viral infections. The be-
lief that influenza vaccination protects against the avian in-
fluenza was shared by 7.2% of the participants. No major 
differences in patients’ knowledge of influenza were ob-
served depending on age and sex.
Practice of influenza vaccination
There were 20.8% of the participants who had been vac-
cinated against influenza in the 12 months before the 
survey. This percentage was similar for both sexes (20.7% 
of men and 20.6% of women, P > 0.05). It was only slightly 
higher for older participants (19.2% in 18-54 age group 
and 23.8% in ≥55 age group, P > 0.05). Altogether 29.7% 
of  participants  had  received  vaccination  in  the  previ-
ous years, 60.0% of whom had also received it in the 12 
months before the survey. Vaccination was most often 
done in the primary health settings, work place, and pa-
tients’ homes (54.1%, 24.1%, and 18.0% of the vaccination 
cases, respectively). Before vaccination, fewer than three 
fourths of vaccinated participants were examined by a 
physician (74.4%). After vaccination, various adverse ef-
fects occurred in 60.2% individuals, most often local pain 
in the place of injection (34.6%), general bad feeling 
(24.1%), and muscle pains (12.0%). Majority of the vac-
cinated participants thought that vaccination had 
item Percentage (%)
meningitis   6.7
death   3.0
susceptibility to infections   2.5
otitis media   2.2
kidney disease   1.4
myositis   0.5
lymphadenopathy   0.3
chronic cough   0.3
Who should by all means receive influenza 
vaccine?†
elderly 41.9
children 36.9
people with low immunity to viral infections 25.0
I do not know 14.4
health service workers 12.5
those in contact with large numbers of people   8.0
everyone   6.4
chronically ill   4.7
teachers   4.4
not everyone needs vaccination   2.5
farmers, people who have contact with animals   2.0
those who had influenza and are susceptible to 
disease
  1.6
pregnant women and breastfeeding mothers   0.5
Who should not receive influenza vaccine?†
healthy, immune people 12.7
chronically ill 11.1
there is no such group of people   8.9
people allergic to influenza vaccine   8.6
infants, and children   6.7
pregnant women and breastfeeding mothers   4.7
people with immune deficiency   4.4
people with medical contraindications   2.2
elderly   1.4
I do not know 42.5
When is the best time to get vaccinated against 
influenza?†
autumn (September-November) 66.3
early autumn, before the influenza season   9.1
spring   7.5
winter (December-February)   3.9
summer   3.3
autumn-winter period   1.6
I do not know 14.7
Does influenza vaccine enhance the immunity 
against all types of viral infections?
yes 19.5
no 47.0
difficult to say 33.4
Does influenza vaccine protect against the 
avian flu?
yes   7.2
no 60.5
difficult to say 31.7
how often should the vaccination against 
influenza be carried out in order to guarantee 
the highest effectiveness?†
1 time a year 63.4
2 times a year   6.6
at least 1 time a year, before each influenza 
season
  3.1
every 2 years or less frequently   0.9
2 years +1 year break   0.2
I do not know 25.6
*Participants could choose more than one answer.
†Answers to the open question.
tAble 2. continued. Knowledge of influenza and influenza 
vaccination among study participants from Poland (n = 640)
item Percentage (%)
tAble 2. continued. Knowledge of influenza and influenza 
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a positive effect on them (65.4%), although some had a 
contrary opinion (3.8%).
The majority of participants who had not had influenza 
vaccination in the 12 months before the study, explained 
it with good health, lack of belief in the vaccine effective-
ness, and the high cost of the vaccine (Table 3). Women 
listed good health as the reason more often than men 
(33.1% vs 22.2%, P < 0.01), whereas men listed lack of belief 
in vaccine effectiveness more often than women (22.2% vs 
13.4%, P < 0.01). Younger patients (18-54 years) listed good 
health as the reason considerably more often than older 
ones (31.4% vs 18.4%, P < 0.01).
The participants most often learnt about the possibility of 
influenza vaccination from their family physicians, televi-
sion, and at work place (Figure 1).
DiSCuSSion
Our study found that low influenza vaccination coverage 
in Poland was related to patients’ false beliefs and high cost 
of influenza vaccination.
Influenza vaccination is a safe, effective, and cost-effective 
method of preventing influenza infections (11). However, 
the rate of influenza vaccination use in Poland is still un-
satisfactory (7). Although it was growing systematically till 
2004 (data from the years 1992-2002 indicate the growth 
of over 200 times, up to more than 100 doses per 1000 of 
population) (12), in the following years the trend was re-
versed, despite lack of problems with vaccination supply. In 
the epidemiological season 2007/08, only 9.5% of the Pol-
ish general population received the vaccine (13). Among 
persons aged 65 and over, the vaccine coverage increased 
only from 7% in 2004 to 14% in 2007 (7). The coverage of 
13.9% of elderly people in Poland in the 2007/2008 sea-
son is the lowest of the 11 studied countries (13). A survey 
conducted in university hospitals found that only 22.3% 
of physicians, 10.6% of nurses, and 13.4% of medical stu-
dents regularly took vaccines against influenza (14). Vac-
cination coverage among health care workers in Poland in 
the 2007/2008 season was 6.4%, the lowest among the 11 
European countries studied (13).
These vaccination rates place Poland far behind other Eu-
ropean  countries,  where  vaccination  coverage  reaches 
25% (15,16), or the USA, where in 2004/2005 season 42% of 
adults from high-risk groups received vaccination, as well 
as 62.7% of people aged over 65 years (17). The WHO en-
tAble 3. reasons for not taking the influenza vaccination among study participants from Poland*
Percent of participants in age group
reason for not taking influenza vaccination
18-54 years 
(n = 344)
55 years and more 
(n = 163)
total 
(n = 507)
Good health 31.4† 18.4† 27.2
Lack of belief in vaccination effectiveness 14.8 20.9 16.8
High cost of vaccination   9.3 10.4   9.7
Lack of time 10.8   5.5   9.1
Used to treat influenza with natural remedies   3.5   6.7   4.5
Due to the health state (chronically sick, was sick in the vaccination period)   2.9   2.5   2.8
Did not have an opportunity to receive vaccination   1.5   3.1   2.0
Had vaccination in previous years, and thinks that it is not necessary to repeat it   2.0   1.8   2.0
Vaccination reduces immunity; once vaccinated, one have to repeat it every year   2.3   0.6   1.8
Difficult to say 21.2 28.8 23.7
*For the open question “Why have you not taken a vaccine against influenza?”; patients were allowed to give more than one answer. this question 
was only answered by those who had not received vaccination within 12 mo before the study, hence the number is lower than the total number of 
participants (507 vs 640).
†χ2 test, P < 0.01.
Figure 1.
Sources of participants’ knowledge on the possibility of influenza vac-
cination, as answers to a closed question. Percentages do not sum up to 
100% since participants were allowed to give more than one answer.131 Kardas et al: Reasons for low influenza vaccination coverage
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couraged member countries to reach the vaccination level 
of 75% among high-risk patient groups by the year 2010, 
as did the European Parliament. Recently, the Council of 
European Union has recommended reaching 75% vacci-
nation coverage in older-age groups as early as possible, 
and preferably by the 2014-2015 winter season (18). There-
fore, the need of popularizing influenza vaccination is of 
the uttermost importance in the Polish society, particularly 
in high-risk groups, such as the elderly and chronically ill, 
and among health care workers.
Participants in this study showed a considerable knowl-
edge of influenza, its symptoms, ways of transmission, and 
complications. However, several illogicalities and miscon-
ceptions are worth pointing out. Over 90% of participants 
were convinced that influenza can be dangerous for health 
but only 42% of them believed that that the elderly were a 
priority population for vaccination. For 11% of participants, 
chronic conditions seemed to be contraindications to vac-
cination. Moreover, a large portion of participants could not 
point out any difference between influenza and other viral 
respiratory tract infections (common colds). Listing runny 
nose as a typical influenza symptom and believing that in-
fluenza vaccination was effective against all types of viral 
infections (almost 20% of participants) were also common 
misconceptions. These misconceptions are important, as in 
many cases, they may lower the motivation for the vaccina-
tion. This is especially important for those who had taken 
the vaccination before. For them, catching a different type 
of viral disease may prove the influenza vaccination to be 
ineffective. According to our study, only 60% of previously 
vaccinated participants had been revaccinated in the year 
before the survey. Therefore, there is a need for campaigns 
designed to increase the influenza vaccination rate in Po-
land that should clearly inform on the scope of influenza 
vaccination effectiveness and the differences between in-
fluenza and other viral respiratory tract infections.
Recent outbreak of the A(H1N1) 2009 virus (“swine flu”) 
and the pandemic announced by the WHO experts con-
tributed greatly to this problem (19). Poland was the only 
EU country that refused to order pandemic vaccine for its 
citizens (20). The Ministry of Health announced an official 
statement in the Polish Parliament in which it not only un-
derestimated the risk of the swine flu, but also questioned 
the effectiveness and safety of the pandemic vaccine (21). 
The Poles believed that message and it went in parallel with 
their reluctance toward vaccination: according to the Euro-
barometer study, as many as 45% of the Poles believed that 
the vaccination against swine flu could not protect them 
from the infection (22). However, it seems that people ex-
tended that message to the regular influenza vaccination 
as well. Recent reports from infective season 2009/2010 
prove that this “negative promotion” of influenza vaccina-
tion in the mass media was very effective: the coverage 
rates dropped to 6.5% of the general population (23).
The most frequently mentioned reason for not taking influ-
enza vaccination was good health. However, it is notewor-
thy that nearly 10% of the participants mentioned financial 
aspects. Similar observations were made in other studies in 
Poland. Kroneman et al showed that in Poland in 2004 and 
2005, 34% and 36% of participants from high-risk groups, 
respectively, had misconceptions preventing them from 
receiving vaccination (ie, they believed they were “resistant 
to influenza”), while 24% of the participants in both years 
stated that they would not have a vaccination due to fi-
nancial difficulties (24). Kalinowski et al found that 37% of 
students did not receive vaccination due to belief in their 
good health and 6% due to the cost of the vaccine (25).
Some authors outside of Poland believe that the lack of 
improvement in influenza vaccination coverage in Poland 
over the last few years and a constant level of patients’ false 
beliefs point to a lack of effective national strategy for in-
fluenza vaccination promotion (26). The strategy should 
embrace free-of-charge provision of influenza vaccination, 
giving priority to the high-risk groups, especially the elder-
ly (27). The need to pay for the vaccination out of pocket is 
a strong discouraging factor. In the USA, it was found that 
introducing a fee of US $10 for a vaccine would decrease 
the number of vaccinated people by 1/3 (28). At the same 
time, there is evidence that reimbursing costs of influenza 
vaccination increases vaccination coverage (29).
High percentage of people who made a conscious decision 
not to receive influenza vaccination in this survey and a lack 
of belief in the effectiveness of vaccination (16.8%) indicate 
that benefits of influenza vaccination should be demon-
strated to the public, particularly to the high-risk groups.
This survey proved that primary health settings were not 
only the most frequent setting where influenza vaccina-
tion takes place, but also the most frequent source of in-
formation about the need for vaccination. This does not 
mean, however, that further action promoting vaccination 
against influenza should not be conducted at this level. 
The experience from other countries teaches us that fam-
ily physicians are those who are most capable of per-
suading  patients  to  receive  influenza  vaccination PANDEMIC INFLUENZA 132 Croat Med J. 2011; 52: 126-33
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(16), and interventions taken at this level, including both 
physicians and patients, contribute to popularization of in-
fluenza vaccination (30,31). Personalized invitations to vac-
cination at family physicians’ practices are worth applying 
in the national program of influenza vaccination, as they 
were found to be particularly effective (27). The media, on 
the other hand, played hardly any role in the promotion of 
influenza vaccination in Poland (25). We hope that such sit-
uation will soon change.
The obvious limitation of this study is the method used for 
participants’ enrolment. Although the study was performed 
in a number of primary health care practices in Lodzkie 
voivodship  and  the  study  sample  corresponds  well  with 
age and sex distribution of the Polish society (Table 1), the 
convenience sample, with overrepresentation of large-city 
dwellers, did not guarantee the full representativeness of 
the study for the Polish population. Moreover, the survey 
covered the people who visited their primary care physician. 
Thus, it could be biased toward people with greater interest 
in one’s health in general and influenza vaccination in par-
ticular. We could not perform further analysis of participants’ 
characteristics except sex and age because almost a quarter 
of them did not state their occupation or stated “other” in 
the questionnaire. Other characteristics were not collected.
Since major reasons for low influenza vaccination cover-
age in Poland include patients’ false beliefs and high cost 
of  vaccination,  it  is  necessary  to  organize  informational 
campaigns that point out the differences between influ-
enza and other viral respiratory tract infections, as well as 
to make the vaccination available free of charge, especially 
for high-risk groups.
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